000 | 03122nam a22004815i 4500 | ||
---|---|---|---|
001 | 978-981-16-9186-7 | ||
003 | DE-He213 | ||
005 | 20240729133642.0 | ||
007 | cr nn 008mamaa | ||
008 | 220607s2022 si | s |||| 0|eng d | ||
020 |
_a9789811691867 _9978-981-16-9186-7 |
||
024 | 7 |
_a10.1007/978-981-16-9186-7 _2doi |
|
072 | 7 |
_aMJCL _2bicssc |
|
072 | 7 |
_aMED062000 _2bisacsh |
|
072 | 7 |
_aMJCL _2thema |
|
245 | 1 | 0 | _aRole of MicroRNAs in Cancers |
250 | _a1st ed. 2022. | ||
264 | 1 |
_aSingapore : _bSpringer Nature Singapore : _bImprint: Springer, _c2022. |
|
300 |
_aXIV, 176 p. 1 illus. _bonline resource. |
||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
347 |
_atext file _bPDF _2rda |
||
505 | 0 | _aChapter 1. Introduction to microRNAs and cancers -- Chapter 2. microRNAs and cancer signaling pathways -- Chapter 3. Role of microRNAs in cell growth proliferation and tumorigenesis -- Chapter 4. Impact of microRNAs in cell adhesion and tumor angiogenesis -- Chapter 5. Modulation of oxidative stress by microRNAs in cancers -- Chapter 6. microRNAs targeting tumor microenvironment and immune modulation -- Chapter 7. Circulating miRNA in prognosis, diagnosis and their role in controlling the fate of cancer stem cells -- Chapter 8. The role of miRNAs in the regulation of drug resistance among different cancers -- Chapter 9. The mechanisms of miRNA deregulation in cancer outbreak -- Chapter 10. Bioinformatic profiling of miRNAs in Cancers. | |
520 | _aThis book discusses the potential roles of miRNA as a crucial regulator in cancer biology. It examines the regulation of drug resistance by miRNAs in cancers and the mechanism of their deregulated expression. The book discusses the role and molecular mechanism of miRNA in regulating cellular proliferation and cell cycle. It analyses circulating miRNAs as biomarkers for cancer diagnosis and prognosis. It also analyzes the role of miRNA as a modulator of the development and function of tumor-associated immune cells. It explores the cross-talk between miRNA and reactive oxygen species (ROS) in pathogenesis, cancer therapeutic tolerance, and resistance. It provides insights into the role of miRNA in cancer angiogenesis, metastasis and describes strategies and associated challenges of miRNA-based therapies. | ||
650 | 0 |
_aCancer _xTreatment. |
|
650 | 0 | _aRNA interference. | |
650 | 0 | _aImmunology. | |
650 | 0 | _aBiochemical markers. | |
650 | 1 | 4 | _aCancer Therapy. |
650 | 2 | 4 | _aRNA Interference. |
650 | 2 | 4 | _aImmunology. |
650 | 2 | 4 | _aBiomarkers. |
700 | 1 |
_aPrasad, DKV. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
700 | 1 |
_aSantosh Sushma, Pinninti. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt |
|
710 | 2 | _aSpringerLink (Online service) | |
856 |
_u#gotoholdings _yAccess resource |
||
912 | _aZDB-2-SBL | ||
912 | _aZDB-2-SXB | ||
245 | _h[E-Book] | ||
999 |
_c100643 _d100643 |